Skip to main content
Premium Trial:

Request an Annual Quote

DeCode to Team with US Preventive Medicine on Genetic Test Offering

NEW YORK (GenomeWeb News) – DeCode Genetics and US Preventive Medicine announced today that they have signed a letter of intent to collaborate on offering genetic testing to US Preventive Medicine customers.
 
Dallas-based US Preventive Medicine offers preventive care, wellness, and disease-management services to employers, consumers, and government agencies. The privately held firm said that it is building a personalized medicine business in the US.
 
“The signing of the letter of intent with DeCode is significant because we will be the first entity in the US and internationally to offer a full continuum of geographically dispersed, comprehensive solutions for personalized medicine,” Christopher Fey, chairman and CEO of US Preventive Medicine, said in a statement.
 
Terms of the alliance were not disclosed.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.